First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast
First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast
ESMO daily: AI integration in breast cancer – a long way ahead?
The ESMO Daily Reporter recently published a summary of the insightful discussions on AI in oncology, a field that is transforming rapidly. Our very own co-founder and CTO, Dr. Mattias Rantalainen, chaired and contributed to this important track.
Stratipath team contributes to foundation model research published in Nature
A method for spatial interpretation of weakly supervised deep learning models in computational pathology
Pharma Times: Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers across the UK and Europe.
This collaboration integrates Stratipath’s technology with Diagnexia’s digital pathology network, providing faster, more precise cancer diagnostics. The partnership aims to improve decision-making for breast cancer treatments.
Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year
Stratipath has been recognized as one of the Gold Companies on NyTeknik – First with news about technology and IT. and Affärsvärlden’s prestigious 33-list – for the maximum three consecutive years!
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry.
Podcast: “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Article at Genomeweb: ”Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Test”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”